These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6488418)

  • 21. Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience.
    Hatgi JN; Wisseman CL; Rosenzweig EC; Harrington BR; Kitaoka M
    Am J Trop Med Hyg; 1966 Jul; 15(4):601-10. PubMed ID: 5941178
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pathology in Malagasy lemurs and their relation to human pathology].
    Coulanges P; Zeller H; Clerc Y; Rodhain F; Albignac R
    Bull Soc Pathol Exot Filiales; 1979; 72(3):272-8. PubMed ID: 554779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal evolution in Malagasy lemurs. V. Chromosomal banding studies of Lemur fulvus albifrons, Lemur rubriventer and its hybrids with Lemur fulvus fulvus.
    Rumpler Y; Dutrillaux B
    Folia Primatol (Basel); 1980; 33(4):253-61. PubMed ID: 7419135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.
    Niedrig M; Lademann M; Emmerich P; Lafrenz M
    Trop Med Int Health; 1999 Dec; 4(12):867-71. PubMed ID: 10632996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of chloroquine prophylaxis on yellow fever vaccine antibody response: comparison of plaque reduction neutralization test and enzyme-linked immunosorbent assay.
    Barry M; Patterson JE; Tirrell S; Cullen MR; Shope RE
    Am J Trop Med Hyg; 1991 Jan; 44(1):79-82. PubMed ID: 1996743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the enzyme-linked immunosorbent assay (ELISA) with standard tests used to detect yellow fever virus antibodies.
    Deubel V; Mouly V; Salaun JJ; Adam C; Diop MM; Digoutte JP
    Am J Trop Med Hyg; 1983 May; 32(3):565-8. PubMed ID: 6344672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yellow fever virus infection. A correlation of complement-fixing antigen with histopathology.
    David-West TS; Smith JA
    Br J Exp Pathol; 1971 Apr; 52(2):114-21. PubMed ID: 5582071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.
    Collaborative Group for Studies with Yellow Fever Vaccine
    Vaccine; 2007 Apr; 25(16):3118-23. PubMed ID: 17316925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A serological survey of arboviruses in the human population of Senegal].
    Renaudet J; Jan C; Ridet J; Adam C; Robin Y
    Bull Soc Pathol Exot Filiales; 1978; 71(2):131-40. PubMed ID: 33772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Arbovirus infections on the island of Nosy-Be; serologic and entomologic findings].
    Fontenille D; Mathiot C; Rodhain F; Coulanges P
    Arch Inst Pasteur Madagascar; 1988; 54(1):101-15. PubMed ID: 3242421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D.
    Querec TD; Pulendran B
    Adv Exp Med Biol; 2007; 590():43-53. PubMed ID: 17191376
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative clinical study of a new 17D thermostable yellow fever vaccine.
    Roche JC; Jouan A; Brisou B; Rodhain R; Fritzell B; Hannoun C
    Vaccine; 1986 Sep; 4(3):163-5. PubMed ID: 3532602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of stabilized yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983].
    Saluzzo JF; Some L; Baudon D; Girault G; Lhuillier M; Kambire PA; Roux JF; Digoutte JP
    Bull Soc Pathol Exot Filiales; 1985; 78(4):536-40. PubMed ID: 4075474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A serological survey of arboviruses in Gabon].
    Jan C; Languillat G; Renaudet J; Robin Y
    Bull Soc Pathol Exot Filiales; 1978; 71(2):140-6. PubMed ID: 743766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurovirulence tests of three 17D yellow fever vaccine strains.
    Minor PD
    Biologicals; 2011 May; 39(3):167-70. PubMed ID: 21536454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of MAC-ELISA for evaluation of yellow fever vaccination.
    Nogueira RM; Schatzmayr HG; Miagostovich MP; Cavalcanti SM; de Carvalho R
    Rev Inst Med Trop Sao Paulo; 1992; 34(5):447-50. PubMed ID: 1342109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
    Barrett AD; Teuwen DE
    Curr Opin Immunol; 2009 Jun; 21(3):308-13. PubMed ID: 19520559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The early cellular signatures of protective immunity induced by live viral vaccination.
    Kohler S; Bethke N; Böthe M; Sommerick S; Frentsch M; Romagnani C; Niedrig M; Thiel A
    Eur J Immunol; 2012 Sep; 42(9):2363-73. PubMed ID: 22733156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological and serological studies of a suspected yellow fever virus outbreak in Mabudi area of Benue Plateau State of Nigeria.
    Tomori O; El-Bayoumi SM; Fabiyi A
    Niger Med J; 1976 Apr; 6(2):135-43. PubMed ID: 16296128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoblotting reveals differences in the accumulation of envelope protein by wild-type and vaccine strains of yellow fever virus.
    Cane PA; Gould EA
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():557-64. PubMed ID: 2732701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.